Wk 7 Breast Cancer Flashcards

(55 cards)

1
Q

3 endocrine risk factors for breast cancer

A
  1. later age at first pregnancy
  2. early menarche & late menopause
  3. HRT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Breast cancer genetics

A

BRCA1 and BRCA2
-there are other less penetrant inherited genes
-all acount for less than 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Breast cancer genetics

A

BRCA1 and BRCA2
-there are other less penetrant inherited genes
-all acount for less than 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

General breast cancer risk factors

A
  1. older age
  2. endocrine factors
  3. obesity
  4. diet,EtOH use, sedentary lifestyle
  5. genetics BRCA1, BRCA2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the UofU mammography recommendation?

A

40, yearly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What info do we want from pathology?

A
  1. histologic type
  2. tumor size
  3. grade
  4. margin status
  5. hormone receptor status
  6. HER2 status
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is breast tissue analogy and parts?

A

Like a specialized sweat gland w/ ducts and secretory glands (lobules)
-like a bunch of grapes w/ lobules = grapes, ducts = stems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Breast tissue histology at various ages

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Categories of breast pathology

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Breast Pathology Categories

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Classification of breast lesions according to risk of invasive cancer

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What meds are used for breast cancer?

A

For localized:
tamoxifen
anastrozole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are estrogen and progesterone markers measured?

A
  1. immunohistochemistry
  2. gene expression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is HER2 gene?

A

Encodes a transmembrae protein tyrosine kinase
-related to EGFR
-tumor expression may predict poor px

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ab med to know for HER2

A

Trastuzumab
Pertuzumab (don’t need to know)
-there are others too!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is HER2 measured?

A

IHC (measures the membrane protein)
FISH (looking for extra copies of the gene)

-expressed in 15-20% of invasive breast cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

IHC testing for HER2 expression

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Adjuvent therapies, might be NED but high prevalence of recurrence

A
  1. radiation - local
  2. systemic therapies:
    -chemo
    -hormonal (ER/PR+): tamoxifen, aromatase inhibitors (only post-menopausal)
    -trastuzumab (HER2+)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Adjuvent therapies, might be NED but high prevalence of recurrence

A
  1. radiation - local
  2. systemic therapies:
    -chemo
    -hormonal (ER/PR+): tamoxifen, aromatase inhibitors (only post-menopausal)
    -trastuzumab (HER2+)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Research results from adjuvant radiation therapy

A

No change in overall deaths
but dramatic decrease in recurrences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Research effects of chemotherapy

A

30% reduction in recurrence
25% reduction in death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What type of breast cancer is tamoxifen used for?

A

ER+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the chemotx regimen for metastatic breast cancer?

A

Hormone receptor +: tamoxifen or aromatase inhibitors

Hormone receptor negative, HER2 negative = “triple negative breast cancer” - chemotherapy, many agents

HER2 + - trastuzumab or newer anti-HER2 agents

24
Q

Breast cancer tx flow chart

25
Where does breast cancer often spread?
Bone
26
Mucinous Carcinoma
excellent px -tumor cells stuck in mucous, can't go anywhere -usually in elderly women
27
What is DCIS?
Ductal carcinoma in situ =malignant prolif of cells in ducts w/ no invasion of basement membrane -detected as calcification on mammography that is dystophic calcification on top of necrotic cells in center -more likely ipsilateral *calcifications are not always malignant (ex fat necrosis and sclerosing adenosis) -TX: surgery and tamoxifen for ER+
28
What is the functional unit of the breast?
Terminal duct lobular unit -lobule has glands (produce milk) w/ cancer, can get malignant prolif of cells in the duct (DCIS) bound by basement membrane
29
What are 4 main subtypes of breast cancer?
1. DCIS (ductal carcinoma in situ) - Paget's disease of the nipple (a type of DCIS that walked it's way up to the nipple) 2. IDC (invasive ductal carcinoma) - cells invade basement membrane 3. LCIS (lobular carcinoma in situ) 4. ILC (invasive lobular carcinoma)
30
What is Comedo type DCIS?
High-grade cells w/ necrosis and dystrophic calcification in center of ducts
31
What is Paget's Disease of the breast?
DCIS that extends up ducts to nipple skin -presents as nipple ulceration and erythema -almost always associated w/ an underlying carcinoma
32
Invasive Ductal Carcinoma
-forms duct-like structures in desmoplastic stroma (CT grows w/ tumor as structural support) -most common type of invasice carcinoma -presents as mass (PE or mammo) -advanced can -> dimpling skin or retraction of nipple
33
What are 4 subtypes of invasive ductal carcinoma?
1. tubular carcinoma 2. mucinous carcinoma 3. medullary carcinoma 4. inflammatory carcinoma
34
Tubular carcinoma
-malignant -desmoplastic stroma -2nd cell type is absent (should be epithelial cell and myoepithelial cell) -good px
35
What makes up the breast stroma?
adipose tissue, fibrous tissue, BVs, lymphatic channels
36
What makes up the TDLU?
=terminal duct lobular unit 1. 2 cell layers: -luminal cell, myoepithelial cell 2. intralobular duct 3. intralobular specialized stroma
37
What age range does this breast tissue represent?
pre-menarche
38
Age range w/ associated breast tissue?
premenopausal
39
Age range w/ associated breast tissue?
premenopausal
40
Age range/functional status associated w/ breast tissue?
lactation
41
Fxnal status of breast tissue?
Postmenopausal
42
Apocrine metaplasia and cysts
=fibrocystic changes myoepithelial cells are present -no atypia -no risk of malignancy
43
Proliferative disease w/o atypia
44
Proliferative disease w/ atypia
-atypical lobular hyperplasia (ALH) is E-caderin negative -4-5x relative lifeteim risk for developing cancer
45
What are 3 types of biphasic lesions?
1. fibroadenoma 2. phyllodes tumor 3. gynecomastia
46
What is a fibroadenoma?
-most common benign breast tumor -20's-30's -often multiple and bilateral -hormonally responsive -well-circumscribed mass w/ prolif of epithelial and stromal componenets
47
What is gynecomastia?
-benign condition in males -uni- or bilateral -due to increased circulating estrogens -endogenous causes: cirrhosis, decreased testosterone, Klinefelter syndrome or fxning testicular tumors -exogenous: EtOH, drugs -expansion of stroma w/ mild epithelial hyperplasia
48
What is Phyllodes tumor?
-affects older women -rapid growth of stromal component w/ leaf-like architecture -benign, borderline and malignant forms
49
What are the 2 categories of malignant breast neoplasms?
1. in situ carcinoma (usually doesn't present as a mass) 2. invasive carcinoma
50
What are 3 pathways of sporadic breast cancer?
1. ER+, HER2-: germline BRCA2 -> PIK3CA mutations ->atypical hyperplasia -> DCIS (50-65% of cancers) 2. ER-, HER2-: germline BRCA1 mutations -> TP53 mutations -> BRCA inactivation -> DCIS (15% of cancers) 3. HER2+: germline TP53 mutations -> HER2 amplification->DCIS (20% of cancers)
51
Lobular carcinoma in situ
LCIS (ER+, e-cadherin-) -diffuse multicentric and bilateral -LCIS treated as a disease marker b/c associated risk of invasive cancer similar in both breasts -more likely both breasts -TX: surveillance, tamoxifen
52
Major histological marker of invasive breast carcinoma
loss of myoepithelial cells
53
Grading Invasive Carcinomas
54
Carcinoma histology
55
Histology of ER positive slide